Key result
Review outlines bleeding risks and safety strategies for needle EMG in anticoagulated patients.
Why the study?
Medically induced coagulopathy is a relative contraindication to needle electromyography, and the safety of EMG in patients on anticoagulants and antiplatelet agents requires clarification.
Is needle electromyography safe for patients taking anticoagulants and antiplatelet agents?
Is needle electromyography safe for patients taking anticoagulants and antiplatelet agents?
This review discusses the safety, bleeding risks, and necessary precautions when performing needle electromyography in patients on anticoagulants and antiplatelet agents.
Answers are grounded in this paper and cite their sources.
Requires individualized bleeding risk assessment before needle EMG on antithrombotics; leaves open the need for prospective safety trials.
Needle electromyography (EMG) is a common and safe diagnostic procedure. Although there are no absolute contraindications to performing an EMG, medically induced coagulopathy represents a relative contraindication. The purpose of this article is to discuss EMG safety for patients taking anticoagulants and antiplatelet agents, and to review the current literature regarding bleeding risks. Safety measures used to avoid serious bleeding complications are also discussed.
No takes yet. Share an insight, caveat, or question.
Gertken et al. (2013) conducted a review in Patients taking anticoagulants and antiplatelet agents. Needle electromyography (EMG) was evaluated on Bleeding risks. This review discusses the safety, bleeding risks, and complication avoidance strategies for performing needle electromyography in patients taking anticoagulants and antiplatelet agents.
Synapse has enriched 10 related papers. Consider them for comparative context: